Sweden, Oct. 29 -- Today, 29 October 2025, Alfa Laval has officially broken ground on the Gunnesbo Innovation Centre in Lund, Sweden. This strategic investment marks a major step in Alfa Laval's commi... Read More
South Korea, Oct. 29 -- WISeKey International Holding, a leading global cybersecurity, AI, and IoT company, alongside its subsidiaries WISeSat.Space ("WISeSat"), the pioneering provider of secure sate... Read More
United States, Oct. 29 -- Hydro has launched its first U.S. university research partnership with the University of Michigan, committing USD 2.5 million over five years to advance aluminium recycling a... Read More
United States, Oct. 29 -- Samsung Electronics America announced the launch of a new pilot program with Altitude Trampoline Park, the premier indoor family entertainment destination, to deploy display ... Read More
United States, Oct. 29 -- Samsung Electronics America announced that Samsung TVs will be the first to support HDR10+ content across Disney+ and Hulu titles. HDR10+ enables an even more immersive viewi... Read More
Japan, Oct. 29 -- On October 27, Nippon Yusen Kabushiki Kaisha (NYK Line) and the Port of Duqm Company (PODC) signed a memorandum of understanding during the Duqm Economic Forum 2025 to collaborate on... Read More
United Kingdom, Oct. 29 -- Alstom, global leader in smart and sustainable mobility, has welcomed award-winning author and poet, Patience Agbabi, to its Golders Green Traincare Centre in North London. ... Read More
Spain, Oct. 29 -- Eviden, the Atos Group product brand leading in advanced computing, cybersecurity products, mission-critical systems, and Vision AI, announces that it has been selected by the NATO S... Read More
United States, Oct. 29 -- JLL Capital Markets announced the $8.5 million sale of Tri-Valley GMP, a 42,620-square-foot industrial biomanufacturing facility located at 4696 Willow Rd. in Pleasanton, Cal... Read More
United States, Oct. 29 -- The U.S. Food and Drug Administration (FDA) announced significant action to make it faster and less costly to develop biosimilar medicines, which are lower-cost "generic" alt... Read More